calendar
5,063 catalysts · 5,063 phase readout · 2,336 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
next 91 dayslessmore
MonWedFri
5,063 catalysts · 5,063 phase readout · 2,336 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
no tagged catalysts yet
Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Cocaine Use Disorder (CUD)
Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Asthma
Sponsor: The Hong Kong Polytechnic University. Phase: NA. Conditions: Stroke
Sponsor: Taipei Medical University Shuang Ho Hospital. Phase: NA. Conditions: Older Adults, Cognitive Impairment, Mild
Sponsor: Fudan University. Phase: PHASE2. Conditions: Pancreatic Cancer
Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: . Conditions: Malnutrition
Sponsor: JOTEC GmbH. Phase: . Conditions: Iliac Aneurysm, AAA
Sponsor: Riphah International University. Phase: NA. Conditions: Hearing Impaired Children
Sponsor: SPINEVISION SAS. Phase: . Conditions: Intervertebral Disc Degeneration
Sponsor: Ggz Oost Brabant. Phase: NA. Conditions: Depressive Symptoms
Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Knee Osteoarthritis
Sponsor: Boston Scientific Corporation. Phase: . Conditions: Pain, Chronic
Sponsor: Ohio State University Comprehensive Cancer Center. Phase: . Conditions: Lung Non-Small Cell Carcinoma, GastroEsophageal Cancer, Esophagus Cancer
Sponsor: National Taiwan University Hospital. Phase: . Conditions: Scapular Dyskinesis, Athletic Injuries, Muscle Weakness, Overuse Injury
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma, Recurrent Malignant Endocrine Neoplasm, Recurrent Malignant Female Reproductive System Neoplasm, Recurrent Malignant Male Reproductive System Neoplasm, Recurrent Malignant Mesothelioma, Recurrent Malignant Neoplasm of Multiple Primary Sites, Recurrent Malignant Oral Neoplasm, Recurrent Malignant Pharyngeal Neoplasm, Recurrent Malignant Skin Neoplasm, Recurrent Malignant Soft Tissue Neoplasm, Recurrent Malignant Solid Neoplasm, Recurrent Malignant Thyroid Gland Neoplasm, Recurrent Malignant Urinary System Neoplasm, Refractory Cutaneous Melanoma, Refractory Malignant Bone Neoplasm, Refractory Malignant Endocrine Neoplasm, Refractory Malignant Female Reproductive System Neoplasm, Refractory Malignant Male Reproductive System Neoplasm, Refractory Malignant Mesothelioma, Refractory Malignant Neoplasm of Multiple Primary Sites, Refractory Malignant Oral Neoplasm, Refractory Malignant Pharyngeal Neoplasm, Refractory Malignant Skin Neoplasm, Refractory Malignant Soft Tissue Neoplasm, Refractory Malignant Solid Neoplasm, Refractory Malignant Thyroid Gland Neoplasm, Refractory Malignant Urinary System Neoplasm
Sponsor: [Redacted]. Phase: . Conditions:
Sponsor: University of Rochester. Phase: NA. Conditions: Fetal Alcohol Spectrum Disorders
Sponsor: University of Cape Town. Phase: NA. Conditions: Tuberculosis, COVID-19, HIV Infections
Sponsor: AstraZeneca. Phase: . Conditions: Pulmonary Disease, Chronic Obstructive
Sponsor: Brigham and Women's Hospital. Phase: PHASE1. Conditions: Inflammatory Bowel Diseases, Clostridioides Difficile Infection
Sponsor: Baptist Health South Florida. Phase: PHASE1. Conditions: Spine Metastases
Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE3. Conditions: Infections Joint Prosthetic
Sponsor: Rush University Medical Center. Phase: NA. Conditions: PrEP Uptake, HIV, Prevention
Sponsor: Janssen Research & Development, LLC. Phase: PHASE2. Conditions: Tuberculosis, Multidrug-Resistant
Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Prostate Carcinoma
Sponsor: University Health Network, Toronto. Phase: . Conditions: Lung Cancer, Nonsmall Cell, Lung Cancer
Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
Sponsor: Pfizer. Phase: . Conditions: COVID-19 Vaccination
Sponsor: University Hospital, Grenoble. Phase: . Conditions: Spondyloarthritis (SpA), Rheumatoid Arthritis & Other Inflammatory Polyarthropathies
Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Solid Tumors, Hematologic Malignancy, Gastrointestinal Cancer, Liver Cancer, Pancreatic Cancer, Melanoma, Pre-Malignancy, Lung Cancer
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis. Phase: NA. Conditions: HIV Infection
Sponsor: National University of Singapore. Phase: NA. Conditions: Type 2 Diabetes Mellitus, Cognitive Impairment, Non-insulin-dependent Diabetes Mellitus, Cognitive Dysfunction
Sponsor: Ankara University. Phase: PHASE3. Conditions: Metastatic Renal Cancer
Sponsor: University of Saskatchewan. Phase: NA. Conditions: Vertical Jump Performance
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumors
Sponsor: Aydin Adnan Menderes University. Phase: NA. Conditions: Digital Addiction and Screen Time Management Among Teachers
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis
Sponsor: Cairo University. Phase: . Conditions: Forward Head Posture, Postural Stability, Gait Analysis
Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: EARLY_PHASE1. Conditions: Esophageal Cancer, MRD, ctDNA
Sponsor: City of Hope Medical Center. Phase: PHASE1. Conditions: Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Hairy Cell Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenström Macroglobulinemia
Sponsor: University Hospital, Clermont-Ferrand. Phase: PHASE4. Conditions: Heart Failure, Acute Heart Failure, Chronic Heart Failure
Sponsor: Evergreen Therapeutics, Inc.. Phase: PHASE1. Conditions: Pre-eclampsia
Sponsor: Masonic Cancer Center, University of Minnesota. Phase: PHASE2. Conditions: Acute Lymphoblastic Leukemia, Large B-cell Lymphoma
Sponsor: National Geriatric Hospital. Phase: NA. Conditions: Type 2 Diabetes, Fraity Syndrome, Exercise Intervention
Sponsor: Biocity Biopharmaceutics Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Malignancies
Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Relapsing Multiple Sclerosis (RMS)
Sponsor: Indiana University. Phase: . Conditions: Anxiety Disorders, Stress Disorders, Post-Traumatic, Pregnancy, High Risk, Depressive Disorder, Major, Pregnancy Complications, ADHD - Attention Deficit Disorder With Hyperactivity
Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Smoking Cessation, Tobacco Use Cessation
Sponsor: BioMarin Pharmaceutical. Phase: . Conditions: Phenylketonuria (PKU)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: PHASE1. Conditions: Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca, Multiple Myeloma, Carcinoma, Non-Small -Cell Lung